Publications

Poynten M, McIntyre PB, Mooi FR, Heuvelman KJ, Gilbert GL. Temporal trends in circulating Bordetella pertussis strains in Australia. Epidemiology and Infection 2004;132:185-93. [Abstract]

Van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infectious Diseases 2004;4:139-43. [Abstract]

Elliott E, McIntyre P, Ridley G, Morris A, Massie J, McEniery J, Knight G. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatric Infectious Disease Journal 2004;23:246-52. [Abstract]

Postma MJ, Bos JM, Welte R, de Groot R, Luytjes W, Rümke HC, Beutels P. Do costs of varicella justify routine infant vaccination? Pharmaco-economic and clinical considerations [editorial] . European Journal of Health Economics 2004;5:54-7 . [Abstract]

Butler JRG, McIntyre P, MacIntyre CR, Gilmour R, Howarth AL, Sander B. The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004;22:1138-49. [Abstract ]

Brotherton JML . Where to from here? [letter]. BMJ Rapid response, 8 Mar 2004. [Link]

McIntyre P. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Communicable Diseases Intelligence 2004;28:92-95. [Full text]

Yohannes K, Roche P, Blumer C, Spencer J, Milton A, Bunn C, Gidding H, Kirk M, Della-Porta T. Australia’s notifiable diseases status, 2002. Communicable Diseases Intelligence 2004;28:6-68. [Full text]

Thiry N, Beutels P, Van Damme P, Van Doorslaer E. Economic evaluation of varicella vaccination programmes: a review of the literature [letter - authors' reply] . Pharmacoeconomics 2004;22(2):136-8 . [Abstract]

Hull BP, McIntyre PB, Couzos S. Evaluation of immunisation coverage for Aboriginal and Torres Strait Islander children using the Australian Childhood Immunisation Register. Australian and New Zealand Journal of Public Health 2004;28:47-52. [Abstract]